Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

684
Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
684
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

183
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
183
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

449
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
449
Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

1.1K
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
1.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

204
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
204

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Behavioral consequences of organophosphorus poisoning: Insights from human exposures and rodent models.

Neuroscience and biobehavioral reviews·2026
Same author

Exposure to organophosphorus compounds: best practice in managing timely, effective emergency responses.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine·2023
Same author

"I AM THOR/DUST DAHO": mnemonic devices used by the Paris Fire Brigade to teach initial measures in undertaking a CBRN event.

Critical care (London, England)·2021
Same author

2019 Overview.

CNS neuroscience & therapeutics·2020
Same author

Trends in severe opioid-related poisonings and fatalities reported to the Paris poison control center - a 10-year retrospective observational study.

Fundamental & clinical pharmacology·2020
Same author

The chemical, biological, radiological and nuclear (CBRN) chain of survival: a new pragmatic and didactic tool used by Paris Fire Brigade.

Critical care (London, England)·2019

Related Experiment Video

Updated: Jan 3, 2026

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
09:54

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures

Published on: October 3, 2016

36.9K

Interdependent Factors of Demand-Side Rationale for Chemical, Biological, Radiological, and Nuclear Medical

Mark Lawrence Johnson1,2, Jean Belin3,4, Frederic Dorandeu5,6

  • 1MJ Lawrence Consulting, Munich, Germany.

Disaster Medicine and Public Health Preparedness
|November 19, 2019
PubMed
Summary
This summary is machine-generated.

Developing medical countermeasures (MedCMs) for chemical, biological, radiological, and nuclear (CBRN) threats requires economic models. Understanding demand-side rationale is crucial for effective CBRN MedCM policy and preparedness.

Keywords:
and nuclear agentsbiologicalchemicalfundingmarket demandmedical countermeasurespublic health policyradiological

More Related Videos

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures
09:36

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures

Published on: October 3, 2016

11.5K
Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.5K

Related Experiment Videos

Last Updated: Jan 3, 2026

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
09:54

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures

Published on: October 3, 2016

36.9K
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures
09:36

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures

Published on: October 3, 2016

11.5K
Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.5K

Area of Science:

  • Public Health
  • Health Economics
  • Biosecurity

Background:

  • Global threat of chemical, biological, radiological, and nuclear (CBRN) materials in warfare and terrorism.
  • Medical countermeasures (MedCMs) are vital for mitigating health risks from CBRN agent exposure.
  • Gaps exist in innovative and available MedCMs for certain CBRN-related diseases.

Purpose of the Study:

  • To strengthen policy-making for CBRN MedCMs by analyzing demand-side rationale.
  • To outline an approach for broader assessment of CBRN MedCM needs.
  • To integrate economic models and concepts for evaluating MedCM preparedness.

Main Methods:

  • Compiling and adapting existing economic models and concepts.
  • Characterizing "soft" factors (behavioral and political economics) influencing demand.
  • Examining "hard" factors (past funding models, collaborative infrastructure) for preparedness viability.

Main Results:

  • Inadequate R&D funding and procurement can lead to severe economic losses.
  • Behavioral and political economics significantly impact the demand for CBRN MedCMs.
  • Lessons from public health funding and access infrastructure can improve MedCM preparedness evaluations.

Conclusions:

  • A robust economic framework is essential for effective CBRN MedCM policy.
  • Integrating soft and hard factors provides a comprehensive approach to demand-side rationale.
  • Enhanced preparedness initiatives are economically advantageous compared to the costs of inaction.